Plant Impact Share Discussion Threads

[glenglen] 09/2/2018 09:51

Wan - everything you say is all well and good but the fact remains nothing is actually happening to give me and many others (especially the market) any proof that this company is even a going concern, let alone going to grow. Changes in marketing here and there sound good but are these changes for the good or changes forced out by hope? Who knows but the share price tells the story

[wan] 09/2/2018 07:40

Given the significant strategic relevance of Brazil for Bayer, I note with interest yesterday that the Brazilian antitrust agency, Cade, recently approved Bayer AG’s proposed takeover of Monsanto, with no additional assets sales/remedies required.

This may have at least some bearing on discussions/events!

I also note recent changes in the marketing of Fortalis in the US -

7th Feb 2018
FORTALIS® IS THE ESSENTIAL CROP INPUT


Fortalis news -

[here and there] 05/2/2018 08:57

That is your discussion, not the relevant one to investors. You carry on fella.

I am 100% correct in my analysis of this company. It is why the share price is 6p not 60p.

Perhaps you should spend more time on information that is more pertinent to making money!

[wan] 05/2/2018 08:15

You duck the main points of the discussion, as per usual. You were and are wrong about PI's pipeline and technologies!

I am wide awake, and perhaps more aware than you give me credit for.

[here and there] 05/2/2018 07:58

Wan, wake up! All these fine words are meaningless. Company way too dependent on one product, customer and country, it goes wrong, they put up the white flag. Real cheap financing or new equity 'partner' who will take half the company, a cheap sell out, sell off major product or go bust and there is a fire sale...take your pick!

[wan] 03/2/2018 09:28

Mthead, you are behind the curve. And talk of me being biased is rich coming from someone that is 'off the scale' in terms of being pessimistic!

Launched products;

Veritas and Fortalis is based on PI's CaT technology (optimisation and mobilisation of calcium).

Banzai is based on PI's Alethea technology (stimulates plants to produce more anti-oxidants)

Of course Plant Impact will further develop/optimise their existing technologies e.g. formulation improvements etc, that goes without saying.

However, there are currently four products in late stage development that utilise new molecules/modes of actions, and all are expected to achieve first product sales in one to three years, these are;

Tempus - a foliar spray for soybeans that aids photosynthesis

S0 - Soybean seed treatment, targets include reduced nitrogen fixation

S1 - Soybean seed treatment, targets include poor crop arcitechture

W1 - Spring Wheat seed treatment, targets include tiller reduction

An interesting aspect is the bias in the late stage development for seed treatments, which provides food for thought given the stated interest of large players in acquiring seed technologies, with Syngenta currently being very active in moves to become at least a very strong global number 3 in seeds.

That aside, the prospects for Tempus is quite exciting as one of its attributes is improved weed control via improved weedkiller efficacy. Herbicide resistance is becoming a major issue, so a product that provides a positive yield response and improves weed control should be of great interest to farmers in all geographies.

The discovery phase of PI's R&D activities has started firing on all four cylinders and is providing a rich seam of new molecules. One of which is apparently centred around the discovery of an ethylene inhibitor (a holy grail, which apparently a multi-million $ research partnership between Syngenta and DOW failed to achieve). So, getting access to PI's early stage projects will also be of particular interest to some!

Back to your last point about Bayer;
I covered the Bayer aspect/agreement in detail in my post 1554, but in short, I don't actually think Bayer will be entirely happy to turn their back on PI's development pipeline. Whether Bayer are just too embroiled in acquiring Monsanto and the situation in Brazil to realise or care about that, remains to be seen. Time will tell!

As pointed out, Bayer has extended the Veritas brand to cover cotton, which follows on from the soybean season, and is hardly a negative aspect!

[mthead1968] 02/2/2018 15:06

Wan, I am fully up to speed with what the pipeline contains. The only products anywhere close to late stage are based on either Alethea or CAt technologies. And these are in fact closer to 12 years old than 10.

Perhaps you could explain why, having signed an agreement to have first options on most of our late stage developmental science, Bayer are happy to turn their backs on all these 'golden opportunities'?

Don't bother trying to give me an explanation, your assessment will be too biased to be worth considering.

[wan] 02/2/2018 14:35

Anyone remotely up to speed should treat that last statement (post 1574) with the contempt it deserves! It is complete rubbish and shows a distinct lack of understanding of PI's R&D developments.

I would draw readers attention to Plant Impact's Research and Development Platform and Pipeline Presentation (August 2017)

[mthead1968] 02/2/2018 13:31

All our late stage developments are based on the same (10 year old) technology as Veritas / Fortalis. And this management team have failed miserably in their efforts to make it viable. They have, in point of fact, brought us to the brink of bankruptcy. You can pontificate about facts as much as you like, the reality of it is reflected in the current share value.

[wan] 02/2/2018 13:17

Sounds like you are manipulating the facts to fit a theory!

Given the late stage of some of PI's developments and the fact that the Board recognizes significant revenue potential ahead of the Company in the mid-term, clearly some parties would be interested in buying PI (rather than seeing it refinanced)!

[mthead1968] 02/2/2018 11:29

Of course they had to say that refinancing was still an option. What on earth else would you expect them to say. The fact that it would have been explored in depth beforehand is irrefutable. I would guess that when it became clear that was impossible, the CFO resigned. And the business was set on this trail to likely disaster. There is hope, I have to agree. But very little in reality.
I think the most likely outcome will be a derisory offer from some venture capital co.

[wan] 02/2/2018 11:12

Excerpts and the facts;

13/12/2017 7:00am
UK Regulatory

In the light of yesterday's communication from BCS, and in order to maximize the value of the Company's technology assets, the Board of Plant Impact has now decided to formally investigate all potential strategic options for the business. These options include refinancing, potential divestment of selected assets, or the sale of the Company. The Board has appointed Peel Hunt LLP ("Peel Hunt") as its financial adviser for this process.

The Board is engaged in discussions with certain parties about the sale of the Company, and it now intends to conduct a formal sale process within an accelerated timetable, with the aim of announcing the outcome of the process very early in 2018. Parties with an interest in participating in the formal sale process should contact Peel Hunt using the contact details set out in this announcement.
(END)

Mthead...Your guesswork sits at odds with the RNS, in that in December refinancing was still an option being explored and that parties were 'already' engaged in discussions regarding the sale of the Company.

So there is hope, as opposed to outright hopelessness!

[mthead1968] 02/2/2018 10:30

Worst case scenario. There may not be any interested parties at all.
Don't forget that the refinancing options would have been explored way before the December announcement. They didn't just 'raise the white flag' on a whim. In my view, that makes the current situation pretty hopeless. And the fact that Bayer have refused to buy any more stock in the short or medium term makes any sort rescue even less likely. Bayers actions will send out signals within the industry. And they won't be positive ones.

[wan] 02/2/2018 09:10

Let's not forget that Bayer agreed to a revised purchase plan, which effectively meant that funds raised and envisaged cash flows were adequate. However, Bayer changed their mind, hence causing the Board to explore "all potential strategic options for the business. These options include refinancing, potential divestment of selected assets, or the sale of the Company."

I am still hopeful that there will be interested parties, other than Bayer, that could mean Plant Impact will survive and thrive, and not just be simply bought out!

[here and there] 01/2/2018 18:29

The forward outlook has drastically changed, they are going to run out of cash hence their pronouncements, the sale sign has been put up and the share price has cratered.
There are 65 people employed, a large team of experts, v expensive to make redundant.

I am still gobsmacked that they put up the white flag so readily last year. Why not raise more cash, find new partners and fight on. A bit wet IMHO

[cjac39] 30/1/2018 20:26

some random thoughts that may or may not help:

- bayers merger with monsanto isnt going well
- the brazilians in the chain were pumping up overall sales of a $2bln sales business
- ze german bayer guys got annoyed at this and went to brazil and shut down turnover pumping activities at all costs
- decent selling products, like ours to 4500 individual farmers, were therefore halted. its not a veritas failure as some say - its bayer big picture stuff. for sure unhelpful and reduces next year revs but by no means an indication of failure
- prior to and meanwhile, some stakeholders in PIM were thinking giving Bayer 1x the Gross profit that PIM earn for selling might be uneconomic
- pim has some great proven tech and some unproven super great tech that is closer to realisation than many in the space
- there isnt a controlling shareholder who will smoke all others (v important)
- they have a decent contingent of cash
- they can turn off spending very quickly
- many of their current shareholders bought the story at 31 and forward outlook hasnt changed much

[glenglen] 30/1/2018 14:00

With all the positivity expressed by some that Bayer and others like PI, see them as the ideal partner blah blah blah can we just get a grip on this situation? The share price is 6p - a year ago it was 55p.
Whatever PI or some boffin from Bayer or elsewhere does or says most of us don't care - we care about the share price Will any of this posturing bring the share price up and if so when?

[bigglesbingham] 25/1/2018 21:04

Totally agree!!

[mthead1968] 24/1/2018 08:42

If it were the case that assurances have been given, then perhaps the management would do us shareholders the courtesy of sharing that information with us. After all, they have a legal requirement to do so I believe.

[bigglesbingham] 24/1/2018 07:29

Not sure anyone would be unaware of the plight . Which again leads on to what have they been told about the potential longevity of the company. I just cannot see any potential partner signing agreement with a company without assurances.

[mthead1968] 23/1/2018 10:54

Yes it does. But it most certainly does not imply that a sale of the business will attract an offer of anything over the current share based value.
As for PI being the 'ideal partner to realise this potential', that surely is open to debate. Maybe VIB know nothing of our current plight!

[wan] 23/1/2018 10:18

Mthead...It does however imply that there is life beyond one of your much suggested scenario's!

To quote Dr. Aurélie Nowack, Business Development Manager at VIB "Plant Impact is the ideal partner to realise this potential."

[mthead1968] 23/1/2018 08:41

I take it you mean the same sort of collaboration agreements Carillion was signing in the lead up to their demise. Of course it's business as usual, that's the least we should be expecting, and what they are being handsomely paid to do. It doesn’t remove us from the dire financial straits we are in though does it?

[wan] 23/1/2018 07:31

Indeed, as I stated yesterday, despite the current situation, PI's developments are not standing still and neither is the business!

Today we have another collaboration that grants Plant Impact exclusive development access and a licensing options.

[bigglesbingham] 23/1/2018 07:20

I take on board all of the comments on here and yes I'm concerned with situation. However if the situation is that bad why would companies sign collaboration agreements now, similar to the one announced this morning??